Cordis alerts doctors on Cypher design spec problems

Johnson & Johnson's Cordis unit has sent doctors an alert stating the Cypher stent may not meet design specifications for proper expansion within heart arteries. The alert follows a mid-February warning letter the FDA issued to Cordis about this issue, and it adds to challenges facing the stent that once lead the market but has been passed by offerings from Boston Scientific and Abbott Laboratories. Report

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.